• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. DENALI JUGULAR SYSTEM; VENA CAVA FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. DENALI JUGULAR SYSTEM; VENA CAVA FILTER Back to Search Results
Model Number DL900J
Device Problems Difficult to Remove (1528); Detachment of Device or Device Component (2907)
Patient Problem Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 02/19/2016
Event Type  Injury  
Manufacturer Narrative
Manufacturing review: a lot history review was performed.This is the only complaint to date for this lot number.Therefore, a device history record (dhr) review is not required.Investigation summary: the device was not returned for evaluation.Medical records were provided and reviewed.Approximately, two months and four days of post deployment, patient was planned for filter removal.Through the right internal jugular vein approach, a sheath was advanced over guidewire into the inferior vena cava.Inferior vena cavogram was performed which demonstrated no evidence of thrombus.A snare catheter was advanced through the sheath and utilized to retrieve the filter.Multiple attempts were made to remove the filter with the center with no success.Then a decision was made to utilize the endobronchial forceps.An endobronchial forceps was then advanced through the sheath.After multiple attempts the filter was then removed.Repeat vena cavogram demonstrated no evidence of inferior vena cava clot.A computed tomography of chest, abdomen and pelvis was performed which demonstrated a curvilinear radiopaque foreign body in the infrarenal inferior vena cava which likely represents one of the struts from a removed vena cava filter.Therefore, decision was made to retrieve the fractured strut.Through the right internal jugular vein approach, inferior vena cavogram was performed.This demonstrated no evidence of inferior vena cava thrombus.The filter strut was seen at the renal vein level.A 12 french sheath was advanced into the inferior vena cava.An endobronchial forceps was advanced through the sheath and attempts were made to retrieve this strut.The strut was migrated into the right ventricle.The sheath was pulled back and the right ventricle was accessed.An ensnare was advanced and attempts were made to retrieve the strut from the ventricle with no success.The strut migrated into a segmental branch of the right pulmonary artery.Then the decision was made to terminate the procedure.Therefore, the investigation is confirmed for filter limb detachment and retrieval difficulties.Based on the available information, the definitive root cause is unknown.Labeling review: a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, and unit label) showed that the product labeling is adequate.(expiry date: 11/2018).
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient after being diagnosed with deep vein thrombosis/pulmonary embolism.At some time post filter deployment, it was alleged that the filter strut detached and embedded in the vena cava.The device was removed percutaneously and the detached strut has not been removed after an attempted but unsuccessful percutaneous removal procedure.The current status of the patient is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DENALI JUGULAR SYSTEM
Type of Device
VENA CAVA FILTER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer Contact
judith ludwig
1415 w. 3rd street
tempe, AZ 85281
4803032689
MDR Report Key12678826
MDR Text Key277876095
Report Number2020394-2021-80787
Device Sequence Number1
Product Code DTK
UDI-Device Identifier00801741040795
UDI-Public(01)00801741040795
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K130366
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,health professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 10/22/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberDL900J
Device Catalogue NumberDL900J
Device Lot NumberGFZJ0454
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/24/2021
Initial Date FDA Received10/22/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ATORVASTATIN, HYDROXYZINE AND LISINOPRIL; OMEPRAZOLE, SENNA-DOCUSATE AND WARFARIN
Patient Outcome(s) Required Intervention;
Patient Age67 YR
Patient Weight117
-
-